{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:28:27Z","timestamp":1793050107281,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.jgp.0000196628.12010.35","type":"journal-article","created":{"date-parts":[[2006,8,12]],"date-time":"2006-08-12T00:34:38Z","timestamp":1155342878000},"page":"767-776","source":"Crossref","is-referenced-by-count":117,"title":["Quetiapine Treatment of Psychosis Associated With Dementia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial"],"prefix":"10.1016","volume":"14","author":[{"given":"Pierre N.","family":"Tariot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira R.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo E.","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Street","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Copenhaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Williams-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.JGP.0000196628.12010.35_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/gps.448","article-title":"Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study","volume":"16","author":"Lyketsos","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/ajp.153.2.243","article-title":"Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease","volume":"153","author":"Aarsland","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1532-5415.1990.tb02407.x","article-title":"A metaanalysis of controlled trials of neuroleptic treatment in dementia","volume":"38","author":"Schneider","year":"1990","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 13","key":"10.1097\/01.JGP.0000196628.12010.35_bib4","first-page":"21","article-title":"Use of quetiapine in elderly patients","volume":"63","author":"Tariot","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0149-2918(00)80085-5","article-title":"Long-term use of quetiapine in elderly patients with psychotic disorders","volume":"22","author":"Tariot","year":"2000","journal-title":"Clin Ther"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib6","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.155.11.1512","article-title":"A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease","volume":"155","author":"Devanand","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archneur.1989.00520440036018","article-title":"A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease","volume":"46","author":"Davangere","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib8","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/geronj\/39.2.187","article-title":"The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit","volume":"39","author":"Overall","year":"1984","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/geronj\/39.2.194","article-title":"The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: II. Representative profile patterns","volume":"39","author":"Beller","year":"1984","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib13","series-title":"Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology (revised)","first-page":"218","author":"Guy","year":"1976"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib14","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00019442-200002000-00010","article-title":"The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement","volume":"8","author":"Wood","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/geronj\/42.4.395","article-title":"Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES)","volume":"42","author":"Helmes","year":"1987","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib19","doi-asserted-by":"crossref","first-page":"P164","DOI":"10.1093\/geronj\/43.6.P164","article-title":"Psychometric assessment of the multidimensional observation scale for elderly subjects (MOSES)","volume":"43","author":"Pruchno","year":"1988","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib21","series-title":"Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019442-200002000-00004","article-title":"Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome","volume":"8","author":"Jeste","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00019442-200307000-00004","article-title":"Psychosis of Alzheimer disease: validity of the construct and response to risperidone","volume":"11","author":"Schneider","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib24","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1016\/S0924-977X(03)92055-4","article-title":"Aripiprazole treatment for psychosis in patients with Alzheimer's disease [Abstract]","volume":"13","author":"De Deyn","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.55.9.1271","article-title":"Treatment of agitation in AD: a randomized, placebo-controlled clinical trial","volume":"55","author":"Teri","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib26","article-title":"Haloperidol for agitation in dementia. [Systematic Review] Cochrane Dementia and Cognitive Improvement Group","volume":"2","author":"Lonergan","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","volume":"60","author":"Katz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib30","first-page":"534","article-title":"A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients [Abstract]","volume":"31","author":"Satterlee","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial","volume":"57","author":"Street","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.1032","article-title":"Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease","volume":"19","author":"De Deyn","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.ajgp.9.1.58","article-title":"Placebo-controlled study of divalproex sodium for agitation in dementia","volume":"9","author":"Porsteinsson","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000196628.12010.35_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/gps.653","article-title":"Sodium valproate in the treatment of aggressive behavior in patients with dementia\u2014a randomized placebo controlled clinical trial","volume":"17","author":"Sival","year":"2002","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112607118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112607118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T10:26:25Z","timestamp":1547461585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112607118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1064748112607118"],"URL":"https:\/\/doi.org\/10.1097\/01.jgp.0000196628.12010.35","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}